Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10265404 | JOURNEY | Compositions, gels and foams with rheology modulators and uses thereof |
Oct, 2030
(6 years from now) | |
US9675700 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US8992896 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US10086080 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US10213512 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US10517882 | JOURNEY | Method for healing of an infected acne lesion without scarring |
Oct, 2030
(6 years from now) | |
US10821187 | JOURNEY | Compositions, gels and foams with rheology modulators and uses thereof |
Oct, 2030
(6 years from now) | |
US8945516 | JOURNEY | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
Oct, 2030
(6 years from now) | |
US10137200 | JOURNEY | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
Oct, 2030
(6 years from now) | |
US8865139 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US10849847 | JOURNEY | Compositions and methods for treating rosacea and acne |
Sep, 2037
(13 years from now) | |
US10398641 | JOURNEY | Compositions and methods for treating rosacea and acne |
Sep, 2037
(13 years from now) |
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Market Authorisation Date: 18 October, 2019
Treatment: Treatment of non-nodular acne vulgaris
Dosage: AEROSOL, FOAM;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US10548875 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(8 years from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10052267 | JOURNEY | Topical glycopyrrolate formulations |
Oct, 2028
(4 years from now) | |
US8618160 | JOURNEY | Topical glycopyrrolate formulations |
Dec, 2029
(5 years from now) | |
US9744105 | JOURNEY | Topical glycopyrrolate formulations |
Jul, 2030
(6 years from now) | |
US9259414 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(8 years from now) | |
US10004717 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(8 years from now) | |
US8859610 | JOURNEY | Crystalline glycopyrrolate tosylate |
Feb, 2033
(8 years from now) | |
US10543192 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(8 years from now) |
Drugs and Companies using GLYCOPYRRONIUM TOSYLATE ingredient
Market Authorisation Date: 28 June, 2018
Treatment: Topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older
Dosage: CLOTH;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8268804 | JOURNEY | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(1 year, 2 months from now) | |
US7790705 | JOURNEY | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(1 year, 2 months from now) | |
US8252776 | JOURNEY | Minocycline oral dosage forms for the treatment of acne |
Jun, 2025
(1 year, 2 months from now) | |
US7919483 | JOURNEY | Method for the treatment of acne |
Mar, 2027
(2 years from now) | |
US7544373 | JOURNEY | Minocycline oral dosage forms for the treatment of acne |
Apr, 2027
(3 years from now) | |
US7541347 | JOURNEY | Minocycline oral dosage forms for the treatment of acne |
Apr, 2027
(3 years from now) |
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Market Authorisation Date: 11 July, 2012
Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8992896 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US9675700 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US8865139 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US10322186 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) | |
US10946101 | JOURNEY | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
Oct, 2030
(6 years from now) | |
US8945516 | JOURNEY | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
Oct, 2030
(6 years from now) | |
US10265404 | JOURNEY | Compositions, gels and foams with rheology modulators and uses thereof |
Oct, 2030
(6 years from now) | |
US10213512 | JOURNEY | Topical tetracycline compositions |
Oct, 2030
(6 years from now) |
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Market Authorisation Date: 28 May, 2020
Treatment: Treatment of inflammatory lesions of rosacea.
Dosage: AEROSOL, FOAM;TOPICAL